β-AR signaling also plays a critical role in immune regulation, with β-AR antagonism reducing myeloid-derived suppressor cells (MDSCs) in tumors and enhancing CD8 + T cell activation and infiltration, thereby supporting anti-tumor responses (32). Here, ADRB2 is linked to neoplasm.